GlassScriptPhysician profile
Ralph Sr Perry
NPI 1558313379
$1,935.68
in general payments reported to CMS, 2019-2025
18 companies · $307 in 2025
The $307 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $170 · 2020: $39.26 · 2021: $158 · 2022: $305 · 2023: $544 · 2024: $412 · 2025: $307.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,263.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,262.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $526.93 | 2022-2025 | Tryptyr, Hydrus Microstent, Total30 |
| Johnson & Johnson Vision Care, INC. | $261.89 | 2019-2023 | Acuvue |
| Bausch & Lomb Americas INC. | $188.47 | 2022-2025 | Miebo, Xiidra, Vyzulta |
| Oyster Point Pharma, INC. | $174.24 | 2022-2024 | Tyrvaya, Ryzumvi |
| Tarsus Pharmaceuticals, INC. | $128.27 | 2024 | Xdemvy |
| Sun Pharmaceutical Industries INC. | $102.45 | 2023 | Cequa |
| Allergan, INC. | $87.68 | 2019-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $81.61 | 2019-2021 | |
| Dompe US, INC. | $64.03 | 2025 | Oxervate |
| Novartis Pharmaceuticals Corporation | $58.42 | 2019-2022 | |
| Aerie Pharmaceuticals, INC. | $49.60 | 2019-2021 | |
| Shire North American Group INC | $44.79 | 2019 | |
| Thea Pharma INC. | $43.49 | 2022-2023 | Iyuzeh |
| Kala Pharmaceuticals, INC. | $42.86 | 2021-2022 | |
| Harrow Eye, LLC | $32.19 | 2024 | Vevye |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $22.07 | 2022 | |
| Eyevance Pharmaceuticals LLC | $15.22 | 2022 | |
| Glaukos Corporation | $11.47 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ralph Perry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.